Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported EPS (Basic) of -$0.0 for Q1 2026, up 96.44% year-over-year from -$0.0 in Q1 2025, and up 93.78% on a QoQ basis from -$0.04 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 17 years of EPS (Basic) data on file, last reported at -$0.0 in Q1 2026.
- Quarterly EPS (Basic) rose 96.44% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.07 (up 86.27% YoY) and the FY2025 annual result came in at -$0.14, up 77.78% from the prior year.
- EPS (Basic) climbed to -$0.0 in Q1 2026 per LXRX's latest filing, from -$0.04 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.01 in Q2 2025 and bottomed at -$0.22 in Q2 2023.
- The 5-year median for EPS (Basic) is -$0.16 (2022), against an average of -$0.13.
- The widest annual swing landed in 2023, when EPS (Basic) plunged 61.54%; it then jumped 105.88% in 2025.
- Tracing LXRX's EPS (Basic) over 5 years: stood at -$0.17 in 2022, then fell by 17.65% to -$0.2 in 2023, then jumped by 55.0% to -$0.09 in 2024, then surged by 55.56% to -$0.04 in 2025, then jumped by 93.78% to -$0.0 in 2026.
- Per Business Quant, the three latest LXRX EPS (Basic) figures stand at -$0.0 (Q1 2026), -$0.04 (Q4 2025), and -$0.04 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.55 |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.20 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.22 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.13 |
| Jun 30, 2022 | -0.16 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -0.13 |
| Mar 31, 2021 | -0.15 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | 0.77 |
| Jun 30, 2020 | -0.65 |
| Mar 31, 2020 | -0.63 |
| Dec 31, 2019 | -0.48 |
| Sep 30, 2019 | 2.13 |
| Jun 30, 2019 | -0.22 |
| Mar 31, 2019 | -0.21 |
| Dec 31, 2018 | -0.16 |
| Sep 30, 2018 | -0.26 |
| Jun 30, 2018 | -0.33 |
| Mar 31, 2018 | -0.40 |
| Dec 31, 2017 | -0.25 |
| Sep 30, 2017 | -0.28 |
| Jun 30, 2017 | -0.33 |
| Mar 31, 2017 | -0.31 |
| Dec 31, 2016 | -0.31 |
| Sep 30, 2016 | -0.35 |
| Jun 30, 2016 | -0.37 |
| Mar 31, 2016 | -0.34 |
| Dec 31, 2015 | 0.84 |
| Sep 30, 2015 | -0.34 |
| Jun 30, 2015 | -0.27 |
| Mar 31, 2015 | -0.27 |
| Dec 31, 2014 | -0.03 |
| Sep 30, 2014 | -0.55 |
| Jun 30, 2014 | -0.35 |
| Mar 31, 2014 | -0.42 |
| Dec 31, 2013 | -0.03 |
| Sep 30, 2013 | -0.06 |
| Jun 30, 2013 | -0.06 |
| Mar 31, 2013 | -0.05 |
| Dec 31, 2012 | -0.05 |
| Sep 30, 2012 | -0.06 |
| Jun 30, 2012 | -0.05 |
| Mar 31, 2012 | -0.06 |
| Dec 31, 2011 | -0.10 |
| Sep 30, 2011 | -0.08 |
| Jun 30, 2011 | -0.08 |
| Mar 31, 2011 | -0.09 |
| Dec 31, 2010 | -0.07 |
| Sep 30, 2010 | -0.08 |
| Jun 30, 2010 | -0.07 |